Recombinant protein corresponding to TGFB/TGF beta [Homo sapiens], expressed in CHO cells.
Fresolimumab has been used in trials studying the treatment of primary brain tumors, metastatic breast cancer, diffuse systemic sclerosis, pleural malignant mesothelioma and primary focal segmental glomerulosclerosis. Applications: Suitable for use in ELISA and SDS-PAGE. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Reinheit:
95%
Formulierung:
Supplied as a liquid in PBS, pH 7.5.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
